Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysis

BACKGROUND: Mesenchymal stromal cells (MSCs) are an emerging prophylaxis option for graft-versus-host disease (GVHD) in haplo-identical hematopoietic stem cell transplantation (haplo-HSCT) recipients with severe aplastic anemia (SAA), but studies have reported inconsistent results. This systematic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ruonan, Tu, Jingke, Zhao, Jingyu, Pan, Hong, Fang, Liwei, Shi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860635/
https://www.ncbi.nlm.nih.gov/pubmed/33541414
http://dx.doi.org/10.1186/s13287-021-02170-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860635/
https://www.ncbi.nlm.nih.gov/pubmed/33541414
http://dx.doi.org/10.1186/s13287-021-02170-7

Ejemplares similares